SCHEMBL24263193

SCHEMBL24263193

C=C(Nc1nc(-c2ccc(CC)cc2C)cs1)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TYR P14679 6/20 0.46
WNT3A P56704 1/20 0.45
MAPT P10636 5/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MRE11 P49959 1/20 0.41
ATP4A P20648 1/20 0.41
ATP4B P51164 1/20 0.41
PKM P14618 1/20 0.40
XIAP P98170 1/20 0.39
RORC P51449 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.38
GAA P10253 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
ABL1 P00519 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24263503 0.78 GSTO1 (0.47) TYRMAPTNPC1RAB9APKM
SCHEMBL26422946 0.72 SMN1; SMN2 (0.37) MAPTSMN1; SMN2HTTGAAMEN1
SCHEMBL3602268 0.66 MAPT (0.56) TYRMAPTNPC1RAB9AATP4A
SCHEMBL17449667 0.65 TYR (0.65) TYRWNT3AMAPTRORCSMN1; SMN2
SCHEMBL21840600 0.65 KMT2A (0.46) TYRWNT3AMAPTNPC1RAB9A
SCHEMBL18550658 0.64 OPRM1 (0.60) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL11484987 0.64 TYR (0.61) TYRNPC1RAB9AGAAABL1
SCHEMBL18560826 0.63 TYR (0.65) TYRMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL12249170 0.63 MAPT (0.58) MAPTSMN1; SMN2LMNAHTT
SCHEMBL18560827 0.63 TYR (0.49) TYRMAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022037927-A1 NEW ISOBUTYRYAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSIBLE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS BEIERSDORF AG (DE) 2022-02-24 WO disclosed